BIOGENERA has appointed as the company’s new chief financial officer (CFO) Dr. Mario Nespoli, who has many years of experience in the pharmaceutical industry at management levels.
Dr. Nespoli served as general manager for REYS Spa, where he created a new management team, opened new branches in the European Union, and invested in new production facilities and equipment.
He also served as CFO for THEA PHARMA Spa, where he developed new control functions, contributed to the growth of internal resources and improvement of SAP processes to support control and SC processes. He also served as Senior Financial Director for BAXALTA PHARMA during a transitional period of extensive restructuring as the company was acquired by SHIRE (now part of Takeda).
